These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8682132)
21. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction). Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B; Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990 [TBL] [Abstract][Full Text] [Related]
22. Primary angioplasty and thrombolysis for acute myocardial infarction: an evidence summary. Lieu TA; Gurley RJ; Lundstrom RJ; Parmley WW J Am Coll Cardiol; 1996 Mar; 27(3):737-50. PubMed ID: 8606291 [TBL] [Abstract][Full Text] [Related]
23. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs. Tsui W; Pierre K; Massel D Can J Cardiol; 2005 Apr; 21(5):423-31. PubMed ID: 15861260 [TBL] [Abstract][Full Text] [Related]
24. Thrombolytic therapy in acute myocardial infarction. Simoons ML Annu Rev Med; 1989; 40():181-200. PubMed ID: 2524993 [TBL] [Abstract][Full Text] [Related]
25. Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction 2. Barron HV; Rundle A; Gurwitz J; Tiefenbrunn A Cardiol Rev; 1999; 7(3):156-60. PubMed ID: 10423667 [TBL] [Abstract][Full Text] [Related]
26. Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands. Vermeer F; Simoons ML; de Zwaan C; van Es GA; Verheugt FW; van der Laarse A; van Hoogenhuyze DC; Azar AJ; van Dalen FJ; Lubsen J Br Heart J; 1988 May; 59(5):527-34. PubMed ID: 3132962 [TBL] [Abstract][Full Text] [Related]
27. Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trial. Aasa M; Henriksson M; Dellborg M; Grip L; Herlitz J; Levin LA; Svensson L; Janzon M Am Heart J; 2010 Aug; 160(2):322-8. PubMed ID: 20691839 [TBL] [Abstract][Full Text] [Related]
28. Thrombolytic therapy for evolving myocardial infarction needs an approach that integrates benefit and risk. Arnold AE; Simoons ML Eur Heart J; 1995 Nov; 16(11):1502-9. PubMed ID: 8881841 [TBL] [Abstract][Full Text] [Related]
29. Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction. de Boer MJ; Reiber JH; Suryapranata H; van den Brand MJ; Hoorntje JC; Zijlstra F Eur Heart J; 1995 Oct; 16(10):1347-55. PubMed ID: 8746902 [TBL] [Abstract][Full Text] [Related]
30. Present treatment of acute myocardial infarction in patients over 75 years--data from the Berlin Myocardial Infarction Registry (BHIR). Schuler J; Maier B; Behrens S; Thimme W Clin Res Cardiol; 2006 Jul; 95(7):360-7. PubMed ID: 16741630 [TBL] [Abstract][Full Text] [Related]
31. Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]). Gierlotka M; Gasior M; Wilczek K; Hawranek M; Szkodzinski J; Paczek P; Lekston A; Kalarus Z; Zembala M; Polonski L Am J Cardiol; 2011 Feb; 107(4):501-8. PubMed ID: 21195380 [TBL] [Abstract][Full Text] [Related]
32. Risk-benefit of thrombolysis. Simoons ML Cardiol Clin; 1995 Aug; 13(3):339-45. PubMed ID: 7585771 [TBL] [Abstract][Full Text] [Related]
33. The ECG as decision support in STEMI. Ripa MS Dan Med J; 2012 Mar; 59(3):B4413. PubMed ID: 22381096 [TBL] [Abstract][Full Text] [Related]
34. Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents. Woo KS; White HD Pharmacoeconomics; 1993 Mar; 3(3):192-204. PubMed ID: 10172049 [TBL] [Abstract][Full Text] [Related]
35. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ; Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591 [TBL] [Abstract][Full Text] [Related]
36. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction. Zeymer U; Schröder R; Machnig T; Neuhaus KL Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324 [TBL] [Abstract][Full Text] [Related]
37. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients. Grijseels EW; Bouten MJ; Lenderink T; Deckers JW; Hoes AW; Hartman JA; van der Does E; Simoons ML Eur Heart J; 1995 Dec; 16(12):1833-8. PubMed ID: 8682015 [TBL] [Abstract][Full Text] [Related]
38. 'Expected infarct size without thrombolysis', a concept that predicts immediate and long-term benefit from thrombolysis for evolving myocardial infarction. Arnold AE; Simoons ML Eur Heart J; 1997 Nov; 18(11):1736-48. PubMed ID: 9402448 [TBL] [Abstract][Full Text] [Related]